Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Mobileye
MBLY
$7.5B
| $19.3M | ﹤0.01% |
1,342,188
+754,479
| +128% | +$12.3M |
|
2727
WisdomTree
WT
$3.37B
| $19.3M | ﹤0.01% |
2,164,165
-51,960
| -2% | -$484K |
|
2728
MGP Ingredients
MGPI
$387M
| $19.2M | ﹤0.01% |
654,323
+92,145
| +16% | +$3.08M |
|
2729
iShares MSCI Thailand ETF
THD
$354M
| $19.2M | ﹤0.01% |
369,804
+162,810
| +79% | +$9.1M |
|
2730
Pediatrix Medical
MD
$2.14B
| $19.2M | ﹤0.01% |
1,323,320
+10,262
| +0.8% | +$146K |
|
2731
Crescent Energy
CRGY
$4.1B
| $19.2M | ﹤0.01% |
1,705,752
-274,442
| -14% | -$3.78M |
|
2732
Atkore
ATKR
$3.17B
| $19.2M | ﹤0.01% |
319,592
-17,184
| -5% | -$1.23M |
|
2733
VanEck Agribusiness ETF
MOO
$978M
| $19.2M | ﹤0.01% |
282,241
+8,768
| +3% | +$595K |
|
2734
MaxCyte
MXCT
$134M
| $19.1M | ﹤0.01% |
7,000,799
+2,592,546
| +59% | +$10.2M |
|
|
WEA
2735
Western Asset Premier Bond Fund
WEA
$125M
| $19.1M | ﹤0.01% |
1,703,059
+164,746
| +11% | +$1.8M |
|
2736
Herbalife
HLF
$1.2B
| $19.1M | ﹤0.01% |
2,209,343
+701,024
| +46% | +$4.99M |
|
2737
Pacer Data & Infrastructure Real Estate ETF
SRVR
$381M
| $19.1M | ﹤0.01% |
649,138
-23,527
| -3% | -$712K |
|
2738
B&G Foods
BGS
$281M
| $19M | ﹤0.01% |
2,771,558
+951,766
| +52% | +$6.35M |
|
2739
Aurinia Pharmaceuticals
AUPH
$2.06B
| $19M | ﹤0.01% |
2,367,762
+722,633
| +44% | +$5.85M |
|
2740
ProShares Short QQQ
PSQ
$647M
| $19M | ﹤0.01% |
468,055
+163,864
| +54% | +$6.2M |
|
2741
Collegium Pharmaceutical
COLL
$873M
| $19M | ﹤0.01% |
636,510
-42,829
| -6% | -$1.31M |
|
2742
Universal Corp
UVV
$1.17B
| $19M | ﹤0.01% |
338,948
+18,990
| +6% | +$1.01M |
|
|
FCT
2743
First Trust Senior Floating Rate Income Fund II
FCT
| $19M | ﹤0.01% |
1,869,359
+86,941
| +5% | +$897K |
|
2744
Knowles
KN
$3.29B
| $18.9M | ﹤0.01% |
1,245,417
+212,119
| +21% | +$3.8M |
|
2745
Marriott Vacations Worldwide
VAC
$4.03B
| $18.9M | ﹤0.01% |
293,915
+50,007
| +21% | +$3.98M |
|
2746
MasterBrand
MBC
$1.87B
| $18.9M | ﹤0.01% |
1,445,716
-566,366
| -28% | -$8.61M |
|
2747
Alpha Metallurgical Resources
AMR
$1.95B
| $18.9M | ﹤0.01% |
150,716
+12,750
| +9% | +$2.07M |
|
2748
Hope Bancorp
HOPE
$1.82B
| $18.9M | ﹤0.01% |
1,800,428
-393,642
| -18% | -$4.42M |
|
|
SAFE
2749
Safehold
SAFE
$1.11B
| $18.8M | ﹤0.01% |
1,006,425
+36,876
| +4% | +$648K |
|
2750
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.25B
| $18.8M | ﹤0.01% |
200,392
-76,687
| -28% | -$7.26M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.